1259065-07-0 Usage
Uses
Used in Pharmaceutical Industry:
1-tert-butyl 4-methyl azepane-1,4-dicarboxylate is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and chemical properties make it a valuable building block in the development of new drugs.
Used in Medicinal Chemistry:
1-tert-butyl 4-methyl azepane-1,4-dicarboxylate is utilized in medicinal chemistry for the design and synthesis of bioactive molecules. Its presence in drug candidates can potentially enhance their pharmacological properties, such as potency, selectivity, and bioavailability.
Used in Organic Chemistry:
1-tert-butyl 4-methyl azepane-1,4-dicarboxylate serves as a versatile reagent in organic chemistry, enabling the synthesis of a wide range of organic compounds. Its functional groups, such as the carboxyl groups, can participate in various chemical reactions, facilitating the formation of diverse molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 1259065-07-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,9,0,6 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1259065-07:
(9*1)+(8*2)+(7*5)+(6*9)+(5*0)+(4*6)+(3*5)+(2*0)+(1*7)=160
160 % 10 = 0
So 1259065-07-0 is a valid CAS Registry Number.
1259065-07-0Relevant academic research and scientific papers
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
-
Page/Page column 33, (2016/05/19)
The present invention provides compounds of Formula I : (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and proph
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
-
Page/Page column 52, (2016/08/23)
The present invention provides compounds of Formula I (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.
3-SPIROCYCLIC PIPERIDINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS
-
Page/Page column 64, (2012/12/13)
The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicam
